Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00969111 · ClinicalTrials.gov registry record · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
A NA study of Prostate Cancer, sponsored by Proton Collaborative Group.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 4
- Study locations
NCT00969111: Recruiting NA study of Prostate Cancer, sponsored by Proton Collaborative Group.
NCT00969111 is a NA study of Prostate Cancer that is actively recruiting participants, run by Proton Collaborative Group. The registered enrollment target is 70 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (88% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00969111, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Proton Collaborative Group.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returned or the risk of prostate cancer returning.
Conditions Studied
Interventions
- RADIATION IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE
- RADIATION Proton (prostate bed) to 70.2 CGE
- RADIATION IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE
- RADIATION Proton to 66.6 CGE
Study Locations (4)
Arkansas
- Proton Center of Arkansas - Little Rock
Florida
- University of Florida Proton Therapy Institute - Jacksonville
Illinois
- Northwestern Medicine Chicago Proton Center - Warrenville
Virginia
- Inova Schar Cancer Institute - Fairfax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2009-08 |
| Est. Completion | 2050-08 |
| Phase | NA |
What NCT00969111 shows while recruiting
NCT00969111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE is the first listed.
NCT00969111 reports a single indexed study location in Arkansas, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT00969111 about?
NCT00969111 is a clinical study titled "Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy". The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returned or the risk of prostate cancer returning.
What is the current status of trial NCT00969111?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2009-08. Estimated completion is 2050-08.
What conditions does trial NCT00969111 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT00969111?
The interventions under investigation include: IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE (RADIATION), Proton (prostate bed) to 70.2 CGE (RADIATION), IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE (RADIATION), Proton to 66.6 CGE (RADIATION).
Who is sponsoring clinical trial NCT00969111?
This trial is sponsored by Proton Collaborative Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00969111 being conducted?
This trial has 4 study locations across Arkansas, Florida, Illinois, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00969111's enrollment target sits among peer trials
70 400th of 735 higher than 333 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
- NCT02616302 · 70 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia